Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Harmony Biosciences Holdings Inc
(NQ:
HRMY
)
39.24
-0.76 (-1.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
442,857
Open
40.55
Bid (Size)
37.72 (1)
Ask (Size)
62.80 (2)
Prev. Close
40.00
Today's Range
38.17 - 40.60
52wk Range
18.61 - 40.60
Shares Outstanding
56,834,745
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says
September 10, 2024
UBS has initiated coverage on Harmony Biosciences with a Buy rating and a price target of $56. UBS highlights Harmony's potential for growth, projecting a 19% CAGR for Wakix sales through 2026.
Via
Benzinga
Unveiling 6 Analyst Insights On Harmony Biosciences
September 10, 2024
Via
Benzinga
Performance
YTD
+27.44%
+27.44%
1 Month
+7.95%
+7.95%
3 Month
+30.80%
+30.80%
6 Month
+20.00%
+20.00%
1 Year
+20.96%
+20.96%
More News
Read More
Harmony Biosciences (HRMY) Q2 2024 Earnings Call Transcript
August 06, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Analyst Expectations For Harmony Biosciences's Future
August 06, 2024
Via
Benzinga
HRMY Stock Earnings: Harmony Biosciences Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
Via
InvestorPlace
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
August 06, 2024
From
Harmony Biosciences
Via
GlobeNewswire
A Glimpse Into The Expert Outlook On Harmony Biosciences Through 7 Analysts
June 21, 2024
Via
Benzinga
Key Takeaways From Harmony Biosciences Analyst Ratings
April 30, 2024
Via
Benzinga
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
Via
InvestorPlace
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
July 01, 2024
Via
InvestorPlace
7 Biotech Stocks to Buy on the Dip: June 2024
June 24, 2024
Via
InvestorPlace
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
May 14, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript
April 30, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Evaluating Harmony Biosciences: Insights From 8 Financial Analysts
March 28, 2024
Via
Benzinga
Analyst Ratings For Harmony Biosciences
February 22, 2024
Via
Benzinga
NASDAQ:HRMY stands out as a growth opportunity that won't break the bank.
January 10, 2024
Via
Chartmill
HRMY Stock Earnings: Harmony Biosciences Beats EPS, Misses Revenue for Q1 2024
April 30, 2024
Via
InvestorPlace
Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View
April 30, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
April 30, 2024
From
Harmony Biosciences
Via
GlobeNewswire
Updates: HRMY, MELI, SWAV
February 28, 2024
Via
Talk Markets
Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript
February 22, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
February 22, 2024
From
Harmony Biosciences
Via
GlobeNewswire
The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024
February 12, 2024
Via
InvestorPlace
The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024
February 07, 2024
Via
InvestorPlace
NASDAQ:HRMY: good value for what you're paying.
January 25, 2024
Via
Chartmill
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.